Bitter melon extract (Insumate®)

Product description

Insumate® bitter melon extract contains the patented amino peptide sequence mcIRBP-19, which is a scientific-recognized active compound for glucose modulation. The clinical efficacy of Insumate® has been validated by two officially clinical studies. It is easy to be absorbed by human body due to the low molecular weight of mcIRBP-19. The underlying mechanism of glucose modulation has been verified by in-vitro and animal models.  
Insumate® (NDIN No. 1256) is the first USFDA-approved bitter melon product.

Insumate® is produced by a unique fabrication process at low temperatures to ensure the product quality and remain the activity of mcIRBP-19. Currently, Greenyn is the only provider and ODM for Insumate®-associated products.
Read more

Specifications

Categories Botanical Extracts; Food Supplements / Nutraceuticals; Functional Food
Sales markets Asia; North America
Supplied from Taiwan, China
Product Applications Dietary Supplements; Food Supplements; Natural And Traditional Remedies; Personal Care
Product Certifications Halal; Health & Safety (GMP, HAACP and equivalents); Quality assurance

More products from Greenyn Biotechnology CO., LTD.

Products from other suppliers

Bitter melon extract (Insumate®)

Contact information

Address

Email

Telephone

Website

View all contact information